0 Yorumlar
0 Paylaşımlar
48 Görüntülenme
0 İncelemeler
Ara
Yeni insanlar keşfedin, yeni bağlantılar kurun ve yeni arkadaşlar edinin
👥
0
🟢
0
-
Beğenmek, paylaşmak ve yorum yapmak için lütfen giriş yapın!
-
From Insight to Action: Liquid Biopsy MarketGlobal LiDAR Drone Market size and share is currently valued at USD 197.14 million in 2024 and is anticipated to generate an estimated revenue of USD 2,376.83 million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 28.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034 LiDAR drones...0 Yorumlar 0 Paylaşımlar 597 Görüntülenme 0 İncelemeler
-
Head and Neck Cancer Market: How Is Liquid Biopsy and Molecular Diagnostics Creating the Precision Monitoring Revenue Stream?Liquid biopsy technologies for head and neck cancer — the circulating tumor DNA (ctDNA), circulating tumor cells (CTC), and HPV DNA detection assays enabling non-invasive treatment monitoring, recurrence detection, and minimal residual disease assessment — create the diagnostic companion market segment, with the Head and Neck Cancer Market reflecting molecular diagnostics as the...0 Yorumlar 0 Paylaşımlar 74 Görüntülenme 0 İncelemeler
-
Liquid biopsy Market Outlook 2024-2035: Competitive Insights, Revenue Projections & Segment ExpansionThe latest report entitled 'Liquid biopsy Market' by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe. The liquid biopsy market size is estimated to grow from USD 6.09 billion in 2024 to USD 29.8 billion by 2035, growing at a CAGR of 15.53% from 2024 to 2035. The report turns...0 Yorumlar 0 Paylaşımlar 1K Görüntülenme 0 İncelemeler
-
Liquid Biopsy Market Transforming Cancer Diagnostics and Precision MedicineThe liquid biopsy market is rapidly redefining how cancer is detected, monitored, and treated. Unlike traditional tissue biopsies, liquid biopsy relies on a simple blood sample to identify tumor-derived components such as circulating tumor DNA (ctDNA), RNA, and exosomes. This non-invasive approach is emerging as a cornerstone of precision medicine, enabling clinicians to make...0 Yorumlar 0 Paylaşımlar 200 Görüntülenme 0 İncelemeler
-
Precision Cancer Diagnostic Tests Market Expansion Across Liquid Biopsy ApplicationsThe global precision cancer diagnostic tests market is witnessing remarkable growth due to the increasing demand for personalized medicine, advancements in molecular diagnostics, and rising cancer prevalence worldwide. Precision cancer diagnostics play a critical role in identifying genetic mutations, biomarkers, and molecular characteristics of tumors, enabling healthcare providers to develop...0 Yorumlar 0 Paylaşımlar 179 Görüntülenme 0 İncelemeler
-
Targeted DNA/RNA Sequencing Market: How Is Liquid Biopsy Creating the Fastest-Growing Market Segment?Liquid biopsy creating fastest-growing targeted sequencing segment — the commercial development of targeted next-generation sequencing of cell-free DNA (cfDNA) in blood — enabling non-invasive detection of somatic tumor mutations, copy number alterations, and gene fusions from circulating tumor DNA (ctDNA) shed by tumors into the bloodstream — creating a clinical testing...0 Yorumlar 0 Paylaşımlar 42 Görüntülenme 0 İncelemeler
-
US Liquid Biopsy Market Revenue, Demand and Forecast AnalysisLiquid biopsy has emerged as a transformative technology in modern oncology and precision medicine. The growing demand for non-invasive diagnostic techniques, rising prevalence of cancer worldwide, and increasing adoption of personalized medicine are significantly contributing to market growth. Liquid biopsy enables the detection of cancer biomarkers through blood samples, eliminating the need...0 Yorumlar 0 Paylaşımlar 153 Görüntülenme 0 İncelemeler